Expert Interview
Discussing the ASCO data from the MIRASOL trial of Immunogen's ELAHERE in patients with platinum-resistant ovarian cancer
Ticker(s): IMGNInstitution: University College London
- Professor of Medical Oncology and Clinical Director at UCL Cancer Institute and a Consultant Medical Oncologist at UCL Hospitals, London, UK where he has worked for more than 30 years.
- Sees ~130 new cases of ovarian cancer referred to his center each year.
- Specialises in the treatment of gynaecological cancers and has led several national and international trials in ovarian cancer; has published widely in the areas of clinical trials in gynaecological cancers, experimental therapeutics, guidelines, and education in gynaecological malignancies.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
